Home > Insider Trading > Filing (0001104659-21-082830)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613859	Pra Health Sciences Inc.	PRAH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1285101	Colin Shannon	C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-15	132,986	$11.73	197,929	No	4	M	Direct
Common Stock	Disposition	2021-06-15	142,093	$168.30	55,836	No	4	S	Direct
Common Stock	Disposition	2021-06-15	1,210	$168.75	54,626	No	4	S	Direct
Common Stock	Acquisiton	2021-06-16	88,045	$11.73	142,671	No	4	M	Direct
Common Stock	Disposition	2021-06-16	83,941	$166.44	58,730	No	4	S	Direct
Common Stock	Disposition	2021-06-16	4,104	$167.49	54,626	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-06-15	132,986	$0.00	132,986	$11.73
Common Stock	Stock Option (Right to Buy)	Disposition	2021-06-16	16,242	$0.00	16,242	$11.73
Common Stock	Stock Option (Right to Buy)	Disposition	2021-06-16	71,803	$0.00	71,803	$11.73

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,242	2016-03-02	2023-12-20	No	4	M	Direct
0	2016-03-02	2023-12-20	No	4	M	Direct
77,425	2016-11-16	2023-12-20	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.685 to 168.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.68 to 168.87, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.07 to $167.06, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.08 to $168.14, inclusive.